76045-112-20 : NDC 2026 Code

76045-112-20 : Naloxone Hydrochloride ( Naloxone Hydrochloride )

Additionally :

You can get information about “76045-112-20” NDC code in 76045-112-20 in HTML format

HTML | 76045-112-20 in TXT (Plain Text) format

TXT | 76045-112-20 in PDF (Portable Document Format)

PDF | 76045-112-20 in XML format

XML formats.

NDC Code : 76045-112-20 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "76045-112-20",
    "PackageDescription": "24 SYRINGE in 1 CASE (76045-112-20)  / 2 mL in 1 SYRINGE (76045-112-01) ",
    "NDC11Code": "76045-0112-20",
    "ProductNDC": "76045-112",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Naloxone Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Naloxone Hydrochloride",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS",
    "StartMarketingDate": "20240402",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA213573",
    "LabelerName": "Fresenius Kabi USA, LLC",
    "SubstanceName": "NALOXONE HYDROCHLORIDE",
    "StrengthNumber": "1",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Opioid Antagonist [EPC], Opioid Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-08-12",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20240402",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}